Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
1) Purpose: To improve pulmonary rehabilitation outcomes for individuals with COPD by evaluating the effectiveness of a hip-assisted exoskeleton during a single pulmonary rehabilitation session. 2) Eligibility criteria: Participants must be between 45-75 years old, any gender, but must have a BMI of less than 35 kg/m^2, free from co-morbidities that may affect walking patterns, and must have moderate to severe COPD with no other pulmonary or cardiac issues. (Eligible participants will undergo a screening process which includes 6-minute walking test, medical history exam, and spirometry evaluation.) 3) Intervention and evaluation: The experimental collection will be conducted at the Biomechanics Research Building at the University of Nebraska at Omaha. Participants are required to participate in two sessions on two separate days, both including a 30-minute walking session with one session wearing the hip exoskeleton and the other session without the device.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard Walking (No Hip Exoskeleton) | No Intervention | Subjects will walk on a treadmill at a preferred speed. | |
| Hip Exoskeleton-Assisted Walking | Experimental | Subjects will walk on a treadmill while wearing a hip exoskeleton providing them assistance. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hip Exoskeleton-Assisted Walking | Device | The intervention is a wearable hip exoskeleton designed to provide assistive torque during treadmill walking. During the assisted walking condition, participants will wear the exoskeleton secured around the waist and thighs. The device will provide powered assistance to the hip joints during walking to reduce the physical demand of locomotion. Participants will complete a 30-minute treadmill walking session at an individualized workload determined during an initial exercise calibration visit. The effects of hip exoskeleton assistance will be evaluated by comparing physiological, respiratory, biomechanical, and exercise tolerance outcomes with a standard walking condition performed without exoskeleton assistance. |
| Measure | Description | Time Frame |
|---|---|---|
| Respiratory Rate and Timing | Measured continuously in real-time using Respiratory Inductance Plethysmography bands worn around the chest and abdomen. | Continuous assessment during the 30-minute treadmill walking bout within each single-day experimental session. |
| Locomotor-Respiratory Coupling (LRC) Ratios | Quantifies the frequency coupling and synchronization between breathing cycles (via RIP bands) and walking cycles (via an SMTEC footswitch system to detect heel strikes). | Continuous assessment during the 30-minute treadmill walking bout within each single-day experimental session. |
| Dyspnea (Perceived Breathlessness) | Evaluated at the end of each exercise bout using the Modified Borg Scale, ranging from 0 (no breathlessness) to 10 (maximum breathlessness) | Assessed at the end of each treadmill walking bout during the 30-minute exercise session. |
| Dynamic Hyperinflation | Evaluated by monitoring the reduction in Inspiratory Capacity (the maximum volume of air inhaled after a regular, calm exhalation) via baseline and post-exercise spirometry. | Measured via spirometry at baseline (pre-exercise) and immediately following the treadmill walking session. |
| Walking Kinematics | Captured at 100 Hz using a 17-camera high-speed digital motion capture system with reflective anatomical markers placed on the lower limbs. | Continuously recorded during the active 30-minute treadmill walking period in each session. |
| Total Walking Time | Measured precisely using digital stopwatches to record the exact duration of walking bouts during the 30-minute session. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UNO Biomechanics | Omaha | Nebraska | 68182 | United States |
As this is a pilot study intended to generate preliminary data and establish feasibility, individual participant data (IPD) will not be publicly shared at this stage. Data sharing will be re-evaluated during future, fully powered randomized clinical trials.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Recorded as the exact cumulative duration of all active walking bouts during the 30-minute session. |
| Metabolic Cost / Metabolic Equivalents of Task (METs) | Determined by measuring net O2 consumption and CO2 production using indirect calorimetry. | Continuous assessment during the 30-minute treadmill walking bout within each single-day experimental session. |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |